BioCentury | Sep 27, 2019
Company News

Blade eyeing fibrosis combos with acquisition of PharmAkea-spinout

...and its autotaxin inhibitor PAT-409. President and CEO Wendye Robbins said PAT-409 is complementary to Blade Therapeutics Inc.’s...
...Calpain 2; CAPN9 - Calpain 9; TGFβ - Transforming growth factor β Elizabeth S. Eaton, Staff Writer Blade Therapeutics Inc. PharmAkea...
BioCentury | Jul 19, 2019
Preclinical News

July 19 Preclinical Quick Takes: Samumed's Alzheimer's candidate; plus a CRISPR RNA editing tool, new targets for fibrosis and pain

...ADAR for A to I conversion. Blade co-founder identifies new fibrosis target Fibrotic diseases company Blade Therapeutics Inc....
...1; TGFβ - Transforming growth factor β; XBP1 - X-box binding protein 1 Mary Romeo, Assistant Editor SM07883 Blade Therapeutics Inc. Dana-Farber...
BioCentury | Mar 1, 2018
Company News

Management tracks: Alkermes, Helsinn

...CBO and CFO. He was SVP and COO at Halozyme Therapeutics Inc. (NASDAQ:HALO). Anti-fibrotic play Blade Therapeutics Inc....
BioCentury | Aug 22, 2017
Company News

Management tracks: Akari, Turnstone, Iconic

...head of a protein degradation discovery performance unit at GlaxoSmithKline plc (LSE:GSK; NYSE:GSK). Anti-fibrotic play Blade Therapeutics Inc....
BioCentury | Jun 21, 2017
Company News

Management tracks

...promoted Peter Khoury to president and CEO from SVP and chief commercial officer. Fibrosis company Blade Therapeutics Inc....
BioCentury | Jun 20, 2016
Financial News

Blade Therapeutics completes venture financing

Blade Therapeutics Inc. , South San Francisco, Calif. Business: Pulmonary, Autoimmune Date completed: 2016-06-16 Type: Venture financing Raised: $45 million Investors: Deerfield Management; Pfizer Venture Investments; Novartis Institute for Biomedical Research; Bristol-Myers Squibb Co. ; MPM...
BioCentury | Jun 17, 2016
Financial News

Fibrotic disease company Blade raises $45M

...Anti-fibrotic play Blade Therapeutics Inc. (South San Francisco, Calif.) raised $45 million in a series B round led...
Items per page:
1 - 7 of 7
BioCentury | Sep 27, 2019
Company News

Blade eyeing fibrosis combos with acquisition of PharmAkea-spinout

...and its autotaxin inhibitor PAT-409. President and CEO Wendye Robbins said PAT-409 is complementary to Blade Therapeutics Inc.’s...
...Calpain 2; CAPN9 - Calpain 9; TGFβ - Transforming growth factor β Elizabeth S. Eaton, Staff Writer Blade Therapeutics Inc. PharmAkea...
BioCentury | Jul 19, 2019
Preclinical News

July 19 Preclinical Quick Takes: Samumed's Alzheimer's candidate; plus a CRISPR RNA editing tool, new targets for fibrosis and pain

...ADAR for A to I conversion. Blade co-founder identifies new fibrosis target Fibrotic diseases company Blade Therapeutics Inc....
...1; TGFβ - Transforming growth factor β; XBP1 - X-box binding protein 1 Mary Romeo, Assistant Editor SM07883 Blade Therapeutics Inc. Dana-Farber...
BioCentury | Mar 1, 2018
Company News

Management tracks: Alkermes, Helsinn

...CBO and CFO. He was SVP and COO at Halozyme Therapeutics Inc. (NASDAQ:HALO). Anti-fibrotic play Blade Therapeutics Inc....
BioCentury | Aug 22, 2017
Company News

Management tracks: Akari, Turnstone, Iconic

...head of a protein degradation discovery performance unit at GlaxoSmithKline plc (LSE:GSK; NYSE:GSK). Anti-fibrotic play Blade Therapeutics Inc....
BioCentury | Jun 21, 2017
Company News

Management tracks

...promoted Peter Khoury to president and CEO from SVP and chief commercial officer. Fibrosis company Blade Therapeutics Inc....
BioCentury | Jun 20, 2016
Financial News

Blade Therapeutics completes venture financing

Blade Therapeutics Inc. , South San Francisco, Calif. Business: Pulmonary, Autoimmune Date completed: 2016-06-16 Type: Venture financing Raised: $45 million Investors: Deerfield Management; Pfizer Venture Investments; Novartis Institute for Biomedical Research; Bristol-Myers Squibb Co. ; MPM...
BioCentury | Jun 17, 2016
Financial News

Fibrotic disease company Blade raises $45M

...Anti-fibrotic play Blade Therapeutics Inc. (South San Francisco, Calif.) raised $45 million in a series B round led...
Items per page:
1 - 7 of 7